1. Home
  2. CVAC vs DAO Comparison

CVAC vs DAO Comparison

Compare CVAC & DAO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CVAC
  • DAO
  • Stock Information
  • Founded
  • CVAC 2000
  • DAO 2006
  • Country
  • CVAC Germany
  • DAO China
  • Employees
  • CVAC N/A
  • DAO N/A
  • Industry
  • CVAC Biotechnology: Pharmaceutical Preparations
  • DAO Other Consumer Services
  • Sector
  • CVAC Health Care
  • DAO Real Estate
  • Exchange
  • CVAC Nasdaq
  • DAO Nasdaq
  • Market Cap
  • CVAC 1.2B
  • DAO 1.0B
  • IPO Year
  • CVAC 2020
  • DAO 2019
  • Fundamental
  • Price
  • CVAC $5.41
  • DAO $8.83
  • Analyst Decision
  • CVAC Hold
  • DAO
  • Analyst Count
  • CVAC 3
  • DAO 0
  • Target Price
  • CVAC $6.83
  • DAO N/A
  • AVG Volume (30 Days)
  • CVAC 974.1K
  • DAO 49.5K
  • Earning Date
  • CVAC 08-14-2025
  • DAO 08-21-2025
  • Dividend Yield
  • CVAC N/A
  • DAO N/A
  • EPS Growth
  • CVAC N/A
  • DAO N/A
  • EPS
  • CVAC 0.87
  • DAO 0.17
  • Revenue
  • CVAC $566,039,775.00
  • DAO $762,395,370.00
  • Revenue This Year
  • CVAC N/A
  • DAO $6.70
  • Revenue Next Year
  • CVAC $24.04
  • DAO $13.94
  • P/E Ratio
  • CVAC $6.24
  • DAO $51.64
  • Revenue Growth
  • CVAC 787.60
  • DAO N/A
  • 52 Week Low
  • CVAC $2.37
  • DAO $2.86
  • 52 Week High
  • CVAC $5.72
  • DAO $11.82
  • Technical
  • Relative Strength Index (RSI)
  • CVAC 59.79
  • DAO 54.35
  • Support Level
  • CVAC $5.42
  • DAO $8.74
  • Resistance Level
  • CVAC $5.49
  • DAO $8.88
  • Average True Range (ATR)
  • CVAC 0.07
  • DAO 0.17
  • MACD
  • CVAC -0.06
  • DAO 0.03
  • Stochastic Oscillator
  • CVAC 36.67
  • DAO 98.17

About CVAC CureVac N.V.

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.

About DAO Youdao Inc. each representing one

Youdao Inc develops and markets software applications. It engages in developing technologies to provide learning content, applications, and solutions. The firm operates in three segments: Learning services, Smart devices, and Online marketing services. The majority of its revenue comes from the Learning services segment, which generates revenues from online courses, mainly including Youdao Premium Courses, NetEase Cloud Classroom, and China University MOOC. The learning products segment includes sales of smart devices such as the Youdao Dictionary Pen and the Youdao Pocket Translator. Geographically, all of its revenue is generated from the People's Republic of China.

Share on Social Networks: